Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | integrin beta 2 | 0.0882 | 0.3255 | 0.3255 |
Echinococcus multilocularis | sodium channel protein | 0.0262 | 0.0563 | 0.0563 |
Entamoeba histolytica | hypothetical protein, conserved | 0.2435 | 1 | 0.5 |
Loa Loa (eye worm) | integrin beta-2 | 0.1196 | 0.4618 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.2435 | 1 | 1 |
Echinococcus multilocularis | integrin alpha ps | 0.0276 | 0.0624 | 0.0624 |
Echinococcus granulosus | integrin alpha ps | 0.0276 | 0.0624 | 0.0624 |
Echinococcus granulosus | integrin alpha 3 | 0.0472 | 0.1475 | 0.1475 |
Giardia lamblia | Rrm3p helicase | 0.2435 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0483 | 0.1524 | 0.3301 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0332 | 0.0868 | 0.1466 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.2435 | 1 | 1 |
Echinococcus multilocularis | integrin alpha ps | 0.0276 | 0.0624 | 0.0624 |
Schistosoma mansoni | integrin beta subunit | 0.0698 | 0.2457 | 0.2457 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0184 | 0.0224 | 0.0486 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.2435 | 1 | 0.5 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0616 | 0.2098 | 0.4266 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.0224 | 0.0486 |
Echinococcus multilocularis | integrin beta 2 | 0.0882 | 0.3255 | 0.3255 |
Echinococcus granulosus | sodium channel protein | 0.0262 | 0.0563 | 0.0563 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.2435 | 1 | 0.5 |
Schistosoma mansoni | integrin alpha-ps | 0.0276 | 0.0624 | 0.0624 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.2435 | 1 | 0.5 |
Brugia malayi | Integrin beta pat-3 precursor | 0.1196 | 0.4618 | 1 |
Schistosoma mansoni | hypothetical protein | 0.2435 | 1 | 1 |
Echinococcus multilocularis | integrin alpha 3 | 0.0472 | 0.1475 | 0.1475 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.2435 | 1 | 0.5 |
Echinococcus granulosus | voltage gated sodium channel Nav1 alpha subunit | 0.0262 | 0.0563 | 0.0563 |
Schistosoma mansoni | integrin alpha | 0.0616 | 0.2098 | 0.2098 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.2435 | 1 | 0.5 |
Schistosoma mansoni | integrin alpha-ps | 0.0144 | 0.005 | 0.005 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.2435 | 1 | 1 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.2435 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2435 | 1 | 0.5 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0816 | 0.2967 | 0.6425 |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 0.09 | 0.1949 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.005 | 0.0107 |
Loa Loa (eye worm) | hypothetical protein | 0.0332 | 0.0868 | 0.1881 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.015 uM | Binding affinity against integrin alpha 2b-beta 3 in enzyme linked immunosorbent assay (ELISA) | ChEMBL. | 7507165 |
IC50 (functional) | = 0.17 uM | Inhibition of 10 uM ADP induced platelet aggregation in human platelet rich citrated plasma (PRP) | ChEMBL. | 7507165 |
IC50 (binding) | = 3 uM | Binding affinity against integrin alpha V-beta5 in enzyme linked immunosorbent assay (ELISA) | ChEMBL. | 7507165 |
IC50 (binding) | = 6 uM | Binding affinity against integrin alpha5-beta1 in enzyme linked immunosorbent assay (ELISA) | ChEMBL. | 7507165 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.